The 1H report read interestingly. A mixed bag, as has been noted...

The 1H report read interestingly. A mixed bag, as has been noted before, but some positives for 2H and going into 2015.

Including:
* Commissioning of ADP plant
* 'Pipe fill' sales of Impromy product. This had a big effect on revenues when Celebrity Slim was first released. I see there is a website online now (http://www.probiotec.com.au/our-brands/impromy/)
* The large increase in contract manufacturing seen over the last 12 months, which should be past the 'startup' phase now and seeing decent profits.

I am expecting an average 2H - as the additional revenues from above will be offset by more restructuring costs as the distribution model is changed.

But 2015 financial year looks like it's going to be a cracker.

There is always the odd change of a left field event - such as buyout of dairy assets on the upside... or on the downside a failure to reach agreement to provide decent whey flows to ADP plant meaning some writeoff here.